Loading asset research
NextCure Inc. Common Stock
NXTCNasdaq · USD · StocksQuote as of · Exchange session not verified$6.03
-5.34%
Today
NXTC
Loading 1D prices…
Market cap
$27.6M
Volume
106.7K
52w high
$15.7452w low
$1.55Company profile
NextCure Inc. Common Stock
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company also develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors. The company was incorporated in 2015 and is headquartered in Baltimore, Maryland.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Baltimore, MD, United States
Employees
40
Fiscal year end
1231
CIK
1661059
Session & valuation
Open$6.55
Previous close$6.37
Day high$6.63
Day low$5.76
30-day avg. volume191.5K
Outstanding shares4.6M
Diluted EPS-$19.65
Latest annual period
P/E (trailing)-0.31
P/E (forward)-1.02
Price / book2.02
Beta1.34
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| OPTHOptimi Health Corp. Common Shares | $28.3M | — | — | -$1.20 | -4.24% | Hold |
| IGCIGC Pharma Inc. Common Stock | $29M | $869K | -477.10% | -$0.05 | -1.26% | Hold |
| BYSIBeyondSpring Inc. Ordinary Shares | $29.1M | $0.00 | — | -$0.02 | -5.59% | Unrated |
| TXMDTherapeuticsMD Inc. Common Stock | $25.4M | $3M | -18.83% | -$0.05 | +0.93% | Unrated |
| ABVCABVC BioPharma Inc. Common Stock | $30.1M | $0.00 | — | -$0.39 | +0.93% | Unrated |